CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.75
-0.25 (-2.28%)
Jul 29, 2025, 4:35 PM GMT+1
CRISM Therapeutics Company Description
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.
Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues.
The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024.
CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
CRISM Therapeutics Corporation
| Country | British Virgin Islands |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Andrew Webb |
Contact Details
Address: Kingston Chambers Road Town British Virgin Islands | |
| Website | crismtherapeutics.com |
Stock Details
| Ticker Symbol | CRTX |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | VGG042401262 |
| SIC Code | 1000 |
Key Executives
| Name | Position |
|---|---|
| Andrew Webb | Chief Executive Officer |
| Ae Swanson | Chief Operating Officer |